PeproTech
Enhanced Life Sciences Research through Recombinant Cytokines

In the past 50 years, several significant discoveries in virology have played a crucial role in changing the dynamics of the life sciences industry. Specifically, the epoch-making discovery of cytokines and its role in improving the human immune system has led biologists to investigate the molecule’s activities further. Today, cytokines are synthesized commercially in laboratories to help the researchers in their investigation. Rocky Hill, New Jersey-based PeproTech, is one such company that develops and supplies recombinant cytokines for life sciences research. Founded in 1988, PeproTech produces high-quality cytokine products like mammalian cell-derived recombinant proteins, ELISA Development Kits, cell culture media/supplements, and other cytokine reagents. A company driven by scientists for scientists, PeproTech takes pride in its contribution to research by providing excellent products and quality support.

Over the years, PeproTech has developed and upgraded its product line to be in lockstep with the changing industry trends. The company’s new range of PeproGMP^® Cytokines embodies the best practices for cell therapy, gene therapy, and tissue-engineered products for clinical applications. Fully compliant with the recent compliance regulations, these Cytokines are used in ex vivo manufacturing of auxiliary materials in the cell, gene, and tissue-engineered products. The company is also known for its Enzyme-linked immunosorbent assay (ELISA) kits that help measure recombinant proteins in cell lysates, sera, or other complex solutions. Apart from ELISA kits, it also manufactures proteins—that are tested for compliance with GMP regulations—for use in clinical trials. Besides, PeproTech has a line of PeproGrow™ Cell Culture Media, media supplements, and companion products that are developed utilizing in-house Cytokine solutions.

PeproTech believes in improving continuously and challenging the status quo with new strategies for product development.

To deliver quality products to customers, the company inspects each process closely in the product lifecycle, from conception to end product, in its facilities in California. Additionally, PeproTech executes stringent tests to ensure that all of its products comply with GMP guidelines. Rigorous quality control tests are conducted to check the products’ purity, identity, safety, activity, and consistency.

Over the years, PeproTech has become part of customers’ success stories and strives to serve its clientele better with each passing day. The company considers customers not only as partners but also family and assists them in their research endeavors. The 30-year-old company sees its customer successes as its own and caters to their complete needs in a simple and streamlined manner for maximum outcomes.

Since its inception, PeproTech has stayed committed to producing resources such as protein reagents and research kits. The company’s evolution has seen its employee strength rising considerably over 30 years, cementing its brand value across nations. Furthermore, the spectacular journey that PeproTech has had wouldn’t have been possible without a strong culture. The company’s core values of dedication and sincerity not only bind the team together but also efficiently guide it with the right attitude to handle customers. To expand its reach further, PeproTech is expanding its animal-free manufacturing facility to meet the current and future demands in the field of R&D and product innovation.

Standing at the forefront of the pharma industry, PeproTech looks forward to improving its product line and customer services in the future. Also, the company aims to expand its product distribution to Australia, New Zealand, and other locations and continue supporting the life sciences community.

Quote: “The new range of PeproGMP^® Cytokines embodies the best practices for cell therapy, gene therapy, and tissue-engineered products for clinical applications.”